Browsing Pharmaceutical Biotechnology, Center for by Subject "S. aureus"
Now showing items 1-1 of 1
Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). (Elsevier Inc., 2015-03-15)Francisella tularensis, the causative agent of tularemia, presents a significant biological threat and is a Category A priority pathogen due to its potential for weaponization. The bacterial FASII pathway is a viable ...